학술논문
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
Document Type
Article
Author
Aman, Jurjan; Duijvelaar, Erik; Botros, Liza; Kianzad, Azar; Schippers, Job R; Smeele, Patrick J; Azhang, Sara; Bartelink, Imke H; Bayoumy, Ahmed A; Bet, Pierre M; Boersma, Wim; Bonta, Peter I; Boomars, Karin A T; Bos, Lieuwe D J; van Bragt, Job J M H; Braunstahl, Gert-Jan; Celant, Lucas R; Eger, Katrien A B; Geelhoed, J J Miranda; van Glabbeek, Yurika L E; Grotjohan, Hans P; Hagens, Laura A; Happe, Chris M; Hazes, Boaz D; Heunks, Leo M A; van den Heuvel, Michel; Hoefsloot, Wouter; Hoek, Rianne J A; Hoekstra, Romke; Hofstee, Herman M A; Juffermans, Nicole P; Kemper, E Marleen; Kos, Renate; Kunst, Peter W A; Lammers, Ariana; van der Lee, Ivo; van der Lee, E Laurien; Maitland-van der Zee, Anke-Hilse; Mau Asam, Pearl F M; Mieras, Adinda; Muller, Mirte; Neefjes, Elisabeth C W; Nossent, Esther J; Oswald, Laurien M A; Overbeek, Maria J; Pamplona, Carolina C; Paternotte, Nienke; Pronk, Niels; de Raaf, Michiel A; van Raaij, Bas F M; Reijrink, Merlijn; Schultz, Marcus J; Serpa Neto, Ary; Slob, Elise M A; Smeenk, Frank W J M; Smit, Marry R; Smits, A Josien; Stalenhoef, Janneke E; Tuinman, Pieter R; Vanhove, Arthur L E M; Wessels, Jeroen N; van Wezenbeek, Jessie C C; Vonk Noordegraaf, Anton; de Man, Frances S; Bogaard, Harm J
Source
In The Lancet Respiratory Medicine September 2021 9(9):957-968
Subject
Language
ISSN
2213-2600